Bionano Genomics CMO Alka Chaubey resigns effective July 5, 2026

Bionano Genomics, Inc.

Alka Chaubey, Ph.D. resigned as Chief Medical Officer on June 2, 2026.
Her resignation becomes effective July 5, 2026.
No replacement or reason for departure was disclosed in the filing.

item 5.02

Featured in Daily 8-K Digest

Selected #1 for 2026-06-05. Read digest

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Alka Chaubey

Chief Medical Officer

BNGO · Bionano Genomics, Inc.

Effective: 2026-07-05
Filed: June 5, 2026, 4:00 PM ET

On June 2, 2026, Alka Chaubey, Ph.D. resigned as Chief Medical Officer of Bionano Genomics, Inc. (the “Company”) effective July 5, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alka Chaubey resigned as Chief Medical Officer at Bionano Genomics, Inc..

Action: resigned
Role: Chief Medical Officer

Exact text from the filing

On June 2, 2026, Alka Chaubey, Ph.D. resigned as Chief Medical Officer of Bionano Genomics, Inc. (the “Company”) effective July 5, 2026.

View on SEC.gov

Bionano Genomics, Inc. filing history →

Source: SEC EDGAR

accession 0001411690-26-000036

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.